Xenetic Biosciences (XBIO) Prepaid Assets (2013 - 2026)
Xenetic Biosciences' (XBIO) quarterly Prepaid Assets came in at $247815.0 in Q1 2026, down 20.98% YoY from $313620.0 in Q1 2025, and up 49.02% on a QoQ basis from $166294.0 in Q4 2025.
Xenetic Biosciences (XBIO) Prepaid Assets (2013 - 2026) Analysis & Trends
Xenetic Biosciences (XBIO) has 14 years of Prepaid Assets data on file, last reported at $247815.0 in Q1 2026.
- Quarterly Prepaid Assets fell 20.98% year-over-year to $247815.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $247815.0 (down 20.98% YoY) and the FY2025 annual result came in at $166294.0, down 60.59% from the prior year.
- Prepaid Assets rose to $247815.0 in Q1 2026, from $166294.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q3 2023 to a low of $166294.0 in Q4 2025.
- A 5-year average of $615451.3 and a median of $556094.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets plunged 87.3% — and 2025, when it soared 403.15%.
- Tracing XBIO's Prepaid Assets over 5 years: stood at $556094.0 in 2022, then rose by 8.58% to $603828.0 in 2023, then sank by 30.12% to $421954.0 in 2024, then sank by 60.59% to $166294.0 in 2025, then surged by 49.02% to $247815.0 in 2026.
- The last three Prepaid Assets figures came in at $247815.0 (Q1 2026), $166294.0 (Q4 2025), and $946361.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 182,311.00 |
| Mar 31, 2026 | 247,815.00 |
| Dec 31, 2025 | 166,294.00 |
| Sep 30, 2025 | 946,361.00 |
| Jun 30, 2025 | 573,854.00 |
| Mar 31, 2025 | 313,620.00 |
| Dec 31, 2024 | 421,954.00 |
| Sep 30, 2024 | 188,088.00 |
| Jun 30, 2024 | 716,381.00 |
| Mar 31, 2024 | 552,043.00 |
| Dec 31, 2023 | 603,828.00 |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 876,539.00 |
| Dec 31, 2022 | 556,094.00 |
| Sep 30, 2022 | 319,103.00 |
| Jun 30, 2022 | 448,733.00 |
| Mar 31, 2022 | 732,368.00 |
| Dec 31, 2021 | 479,399.00 |
| Sep 30, 2021 | 878,243.00 |